TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2023

Sustained Viral Suppression With Dolutegravir Monotherapy Over 192 Weeks in Patients Starting Combination Antiretroviral Therapy During Primary Human Immunodeficiency Virus Infection (EARLY-SIMPLIFIED): A Randomized, Controlled, Multi-site, Noninferiority Trial.

Emily West et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.